Focus: InspireMD is an Israeli medical device company focused on interventional cardiology and neurovascular stent systems, operating at a modest scale with niche vascular protection technologies.
Profile data last refreshed Yesterday · AI intelligence enriched 2w ago
No open roles listed right now. Follow InspireMD to get notified when they start hiring — the background below is worth knowing for when they do.
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Phase 4 embolic protection stent system in commercial/post-launch phase for acute MI indication.
Help build intelligence for InspireMD
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.
Generated by Claude from InspireMD's SEC filings, pipeline programs, hiring velocity, FDA actions, and WARN data. Inference, not editorial — verify before quoting.
Flagship carotid intervention device with clinical evidence and established market presence.
Core coronary stent system with embolic protection mechanism for acute coronary syndromes.
No open positions listed yet. Check their careers page directly.
Upgrade to Pro to access AI interview prep brief and other premium pharma intelligence.
Upgrade to Pro — $25/moBased on last 4 crawl cycles